Citation Impact
Citing Papers
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
2011
Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
2012
Synovitis in osteoarthritis: current understanding with therapeutic implications
2017 Standout
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
2010
Methodology in conducting a systematic review of systematic reviews of healthcare interventions
2011 Standout
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
2010
Rheumatoid arthritis
2018 Standout
Rheumatoid arthritis
2016 Standout
Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells
2014
Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
2013
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
2012
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
2009
Use of abatacept in rheumatoid arthritis
2012
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
2009
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
2008
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Rheumatoid arthritis
2010 Standout
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
2009
Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
2015
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
2010
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study
2016
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Actinomyces and Related Organisms in Human Infections
2015 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis
2014
Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis
2010
Novel TNF antagonists for the treatment of rheumatoid arthritis
2009
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
2020
Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial Intelligence
2023 Standout
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
2017
Works of Philippe Cornet being referenced
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
2007
Effets des perturbateurs endocriniens sur les marqueurs de la périnatalité
2013